2010/2011: Past Meetings

Abstract: The use of FRP materials for repair and strengthening of concrete structures will be described. Concepts of repair as well as a description of resins, fibers and material forms will be given. The FRP application process is explained. Finally, a local project, strengthening of the Naval pier at Sandy Hook NJ will be described in detail.

Bio: Howard Kliger is an engineering and marketing consultant to the composites industry specializing in industrial and sports related products. He has also been very active in efforts to bring fiber sheet wrapping materials to the infrastructure market. He has authored numerous papers and has been an active member of SAMPE since 1975. Also, as an Adjunct Professor, he teaches a Mechanics of Solids structures course and a graduate composites course at Rutgers University. Some of the more interesting projects he has worked on during a 40 year career include design and prototype development of composite torque shafts for Nascar racers, design of an all composite flatbed trailer truck, prototype development and material qualification of composite sport goods such as the Prince Vortex tennis racquet and the Abu Garcia Royal Nickel fishing rod, and strengthening of the concrete pier at the Earle Naval Weapons Center at Sandy Hook NJ.

Please join us for this luncheon meeting at 12:30 pm.
MEETING DATE: Thursday, April 14, 2011

To RESERVE: Call 1-973-729-6671 or e-mail: accce@chemconsult.org

Biographical Sketch: Dr. Cheul H. Cho, Ph.D., is an Assistant Professor in the Department of Biomedical Engineering at New Jersey Institute of Technology (NJIT). He is also an Adjunct Assistant Professor of Cell Biology and Molecular Medicine at the UMDNJ-New Jersey Medical School. Prior to his joining NJIT in 2007, he has completed 4-year postdoctoral fellowship in Center for Engineering in Medicine at Harvard Medical School in the field of stem cells and liver tissue engineering. He obtained B.S degree in Chemical Engineering from Dong-A University in Busan, South Korea, M.S. degree in Biomedical Engineering from University of Iowa, and Ph.D. degree in Chemical Engineering from Wayne State University. Previously, he worked as a research scientist in Biomedical Research Center at Korea Institute of Science and Technology (KIST), the well-known national research institute in South, Korea. He has served as an invited reviewer of FASEB Journal, Tissue Engineering, and Journal of Biomedical and Materials Research. He has published over 10 scientific articles and a full patent application on embryonic stem cell differentiation techniques into liver lineage. Dr. Cho has recently received the prestigious Coulter Foundation Translational Awards for his promising patent application.
Please join us for this luncheon meeting at 1 pm.
MEETING DATE: Tuesday, November 30, 2010.

To RESERVE: Call 1-973-729-6671 or e-mail: accce@chemconsult.org

ANNUAL MEMBERSHIP MEETING DATE: Tuesday, October 26th
1928–2010 82nd Anniversary

To RESERVE: Call 1-973-729-6671 or e-mail: accce@chemconsult.org

Downstream pharmaceutical processing consists of a series of unit operations in which an active pharmaceutical ingredient (API) is converted into a final dosage form (e.g. tablet). Typically this encompasses a series of purification steps (crystallization – filtration -drying) followed by the final dosage form production steps (granulation – drying -milling – blending – compression – coating). The focus of this talk is on granulation which is a particle agglomeration process of converting fine powdery solids into larger free-flowing granules. In batch granulation, it is of interest to develop a systematic strategy for scale-up of high-value added products. Currently scale-up is poorly understood and this can lead to batch failure at the production scale. Thus, there is an immediate economic incentive for a more fundamental model-based understanding of the granulation process which could lead to a more efficient operation, control and scale-up of granulation units. Current granulation models are typically empirical and/or semiempirical in nature. As a result, scale-up and control of granulation processes are often based on heuristics and/or operator experience. Many continuous granulation plants operate well below their design capacity, suffering from high recycle rates and instabilities caused by disturbance amplification effects. A granulation model based on first-principles mechanistic understanding (i.e., based on the physics and chemistry of the process) will be presented in this seminar. Results will elucidate that the mechanistic representations of the granule formation could lead to improved scale-up and control. The predictive nature of such models can also result in reduced labor- and capital-intensive experiments required for model calibration.
Dr. Rohit Ramachandran is currently an Assistant Professor at the Department of Chemical & Biochemical Engineering at Rutgers University . He completed his Bachelors and Masters in Chemical Engineering at the National University of Singapore. He then went on to pursue his doctoral studies at Imperial College London, also in Chemical Engineering. This was followed by a postdoctoral position at the Department of Chemical Engineering at MIT. His research interests include modeling, control and optimization related to pharmaceutical and chemical processes. MEETING DATE: Tuesday, September 28, 2010.

To RESERVE: Call 1-973-729-6671 or e-mail: accce@chemconsult.org

Dr. Mike Blumenthal recently received his 50th year pin from the ACS which he joined at age 17. His industrial research background was in physical and analytical chemistry, and process engineering development of lipids and specialty chemicals, food, and packaging. He has operated the Libra Labs affiliated companies for 30 years including an international consulting practice, and was one of the first in the world to design and commercialize scientific and management software suites for personal computers. He is unflagging in his thirst for new knowledge and projects. Mike’s latest interest is in three-dimensional printing which largely depends on the thermal, sensory, and rheological properties of specialty materials, process equipment, and computer control.
Please join us for a Gourmet Hot/Cold Buffet Dinner. Advanced reservations recommended.
MEETING DATE: Thursday, June 24, 2010.

To RESERVE: Call 1-973-729-6671 or e-mail: accce@chemconsult.org

Each year American farmers produce enough food to feed 300 million people, enough feedstocks to produce millions of gallons of ethanol and biodiesel fuels and more than 100 billion dollars worth of additional ag products to export. Over the past 200 years, many scientists have worked to improve seeds, manufacture fertilizers, develop pesticides and reduce environmental pollution. Engineers have built powerful tractors, tillage implements, planters and harvesting equipment. The end result is that less than 2 percent of the American population is involved in production agriculture thus allowing the other 98 percent of the population to enjoy an abundant lifestyle. But, the next challenge is to produce enough food to also feed the additional 100 million people that will be added to our population by 2050 while reducing carbon emissions and environmental impacts. Many new scientists and engineers will be needed to develop the new technologies and equipment to meet this challenge

Richard Schauer was reared on a farm in Central New Jersey, earned a BS and a MS in Agronomy from Rutgers University and earned a Ph.D. in Agronomy from West Virginia University. He spent 14 years with Diamond Shamrock Corporation traveling around the World developing and registering new pesticides. He also spent 14 years at ICI Americas Inc. as a chemical regulatory manager. Since 1992, he has been a chemical regulatory consultant. He keeps up with agricultural practices of his farmer neighbors in rural Delaware as well as growing Christmas trees on his own farm.

Stefano Crema received his PhD in Chemistry from Monash University in Melbourne, Australia, and his Bachelor/Master’s degree in Chemistry from Padua University, Italy. During his more than 25 year career in the chemical industry, Dr. Crema has worked on various projects connected with the energy industry and, lately, was in charge of developing emission reducing additives for automotive applications. He has recently retired from BASF Corporation where he held the position of Research and Development manager in Wyandotte, MI and Director of Marketing in the North American Headquarters in Florham Park, NJ. Dr. Crema has been working since his retirement in 2006 on Global Warming and Renewable Energy issues. In 2008, he started with some colleagues, Cooling America thru Local Leadership (CALL), a non-profit dedicated to the improvement of the energy infrastructure in New Jersey.
Please join us for dinner. Advanced reservations recommended.

BIOGRAPHY: Mr. Lipták arrived from Hungary in the United States in 1956. In 1960, he became the Chief Instrument Engineer at C&R (later John Brown). In 1987, he was an adjunct professor at Yale University and he is currently working as a consultant with assistance (Lipták Associates PC) on industrial optimization. He has published two dozen technical books including: “Post-Oil Energy Technology”, “Optimization of Unit Operations” and “Environmental Engineers’ Handbook”.
Please join us for dinner. Advanced reservations recommended.

Footnotes: ¹Antiviral Research (WP), ²Laboratory Animal Research (WP), ³Drug Metabolism (WP), ⁴Medicinal Chemistry

BIOGRAPHY: David Olsen, Ph.D. has an undergraduate chemistry degree and trained as a biochemist at University of Maryland, College Park MD. David completed postdoctoral research at the Max-Planck Institute for Experimental Medicine (Göttingen, Germany) where he utilized chemistry, molecular biology and biochemical techniques to investigate structure/function of catalytic RNA. After completing his postdoctoral training, David joined the Antiviral Department at Merck in 1991.
David has more then 18 years of antiviral drug discovery and development experience with 59 publications. His career interests have focused on HIV-1 protease and reverse transcriptase and hepatitis C protease and polymerase inhibitory mechanisms. His other research interests include mechanisms of antiviral resistance and enzyme-nucleic acid interaction studies. In 2007 and 2008 David served as a Senior Director and Head of the Department of Antiviral Research in West Point Pennsylvania. In 2009 he transitioned to External Basic Research where he functions as the Site Lead for the Infectious Disease franchise.
In this new role, David expanded his area of drug discovery research to cover Merck’s external research pipeline in the areas of antibacterial, antifungal and antiviral research. His team is responsible for directing a dozen programs based in China, Japan, India and Russia.
Please join us for dinner. Advanced reservations recommended.